MBI researcher honored internationally for mRNA cancer vaccine work
Dr. Elias Sayour was one of three scientists worldwide honored at the 2026 BioInnovation Institute & Science Prize for Innovation ceremony.
Posts tagged as
Elias Sayour
Igniting immunity
Dr. Elias Sayour’s patients inspire his pioneering mRNA cancer vaccine research.
Dr. Elias Sayour’s work wins Clinical Research Forum Top 10 award
Sayour’s study, published in Nature, found that COVID mRNA vaccines spark an immune response to fight cancer.
Media coverage of study finding COVID-19 mRNA vaccine sparks immune response to fight cancer
See highlights stemming from paper published in the journal Nature on Oct. 22.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research
In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.
Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.
From rejection to revolution: mRNA vaccines go beyond infections to diseases in the brain
Dr. Elias Sayour describes his groundbreaking research to find new treatments for glioblastoma for Inside Precision Medicine.
Cancer vaccines are showing promise at last
Groundbreaking study showing fierce immune response to fight malignant brain tumor featured in The Economist.
MBI researcher named 2024 Innovator of the Year
Dr. Elias Sayour earns honor from UF Innovate | Tech Licensing for his work in brain cancer immunotherapy.
Tech Tuesday: Brain cancer vaccines
Dr. Elias Sayour was featured for UF Innovate’s Tech Tuesday, discussing his work to develop mRNA brain cancer vaccines.
